Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTSG NYSE:FMS NASDAQ:GH NASDAQ:NTRA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTSGBrightSpring Health Services$58.49+0.9%$47.30$19.01▼$59.65$11.35B1.712.47 million shs311,719 shsFMSFresenius Medical Care AG & Co. KGaA$21.63-3.9%$22.44$20.02▼$29.71$12.08B0.81660,313 shs105,207 shsGHGuardant Health$118.57+0.5%$90.53$36.36▼$121.01$15.72B1.482.07 million shs740,885 shsNTRANatera$206.21+1.2%$200.78$131.81▼$256.36$29.60B1.571.31 million shs280,843 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTSGBrightSpring Health Services-1.02%-0.70%+25.79%+41.23%+144.27%FMSFresenius Medical Care AG & Co. KGaA+1.42%+4.73%-1.85%-7.76%-24.42%GHGuardant Health+2.64%+19.61%+30.60%+14.46%+218.17%NTRANatera-0.60%+3.44%-0.84%-3.97%+34.81%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTSGBrightSpring Health Services$58.49+0.9%$47.30$19.01▼$59.65$11.35B1.712.47 million shs311,719 shsFMSFresenius Medical Care AG & Co. KGaA$21.63-3.9%$22.44$20.02▼$29.71$12.08B0.81660,313 shs105,207 shsGHGuardant Health$118.57+0.5%$90.53$36.36▼$121.01$15.72B1.482.07 million shs740,885 shsNTRANatera$206.21+1.2%$200.78$131.81▼$256.36$29.60B1.571.31 million shs280,843 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTSGBrightSpring Health Services-1.02%-0.70%+25.79%+41.23%+144.27%FMSFresenius Medical Care AG & Co. KGaA+1.42%+4.73%-1.85%-7.76%-24.42%GHGuardant Health+2.64%+19.61%+30.60%+14.46%+218.17%NTRANatera-0.60%+3.44%-0.84%-3.97%+34.81%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTSGBrightSpring Health Services 3.12Buy$57.00-2.55% DownsideFMSFresenius Medical Care AG & Co. KGaA 1.56Reduce$28.0029.46% UpsideGHGuardant Health 2.86Moderate Buy$129.008.80% UpsideNTRANatera 2.79Moderate Buy$256.6024.43% UpsideCurrent Analyst Ratings BreakdownLatest FMS, NTRA, GH, and BTSG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2026GHGuardant Health Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$127.005/21/2026GHGuardant Health TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/21/2026BTSGBrightSpring Health Services BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$70.005/12/2026NTRANatera Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$249.005/12/2026GHGuardant Health Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$135.005/11/2026NTRANatera BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$260.00 ➝ $250.005/8/2026NTRANatera Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$265.005/8/2026NTRANatera EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$270.005/8/2026GHGuardant Health BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$115.00 ➝ $120.005/8/2026FMSFresenius Medical Care AG & Co. KGaA Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Moderate Sell5/8/2026GHGuardant Health JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$130.00 ➝ $135.00(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTSGBrightSpring Health Services$12.91B0.88$2.19 per share26.66$10.21 per share5.73FMSFresenius Medical Care AG & Co. KGaA$22.20B0.54$5.42 per share3.99$29.76 per share0.73GHGuardant Health$982.02M16.01N/AN/A($1.37) per share-86.55NTRANatera$2.50B11.81N/AN/A$12.39 per share16.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTSGBrightSpring Health Services$190.67M$1.4141.5029.390.772.27%14.63%4.41%7/31/2026 (Estimated)FMSFresenius Medical Care AG & Co. KGaA$1.11B$1.9011.398.904.014.88%8.90%4.05%8/4/2026 (Estimated)GHGuardant Health-$416.28M-$3.39N/AN/AN/A-40.10%N/A-26.42%7/29/2026 (Estimated)NTRANatera-$208.16M-$1.63N/A824.85N/A-9.05%-14.74%-10.27%8/6/2026 (Estimated)Latest FMS, NTRA, GH, and BTSG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026FMSFresenius Medical Care AG & Co. KGaA$0.59$0.53-$0.06$0.25$5.41 billion$5.34 billion5/1/2026Q1 2026BTSGBrightSpring Health Services$0.29$0.39+$0.10$0.67$3.39 billion$3.61 billion3/31/2026Q1 2026FMSFresenius Medical Care AG & Co. KGaAN/A$1.0530N/A$0.25N/A$5.34 billion2/27/2026Q4 2025BTSGBrightSpring Health Services$0.34$0.33-$0.01$0.35$3.38 billion$3.55 billion2/26/2026Q4 2025NTRANatera-$0.46$0.35+$0.81$0.36$600.68 million$665.50 million2/24/2026Q4 2025 (Media)FMSFresenius Medical Care AG & Co. KGaA$0.67$0.83+$0.16$0.67$4.80 billion$5.95 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBTSGBrightSpring Health ServicesN/AN/AN/AN/AN/AFMSFresenius Medical Care AG & Co. KGaA$0.572.53%+2.66%30.00%N/AGHGuardant HealthN/AN/AN/AN/AN/ANTRANateraN/AN/AN/AN/AN/ALatest GH, NTRA, FMS, and BTSG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2026FMSFresenius Medical Care AG & Co. KGaAannual$0.87163.87%5/22/20265/22/20266/8/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTSGBrightSpring Health Services1.241.741.38FMSFresenius Medical Care AG & Co. KGaA0.401.200.86GHGuardant HealthN/A4.684.39NTRANateraN/A2.962.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTSGBrightSpring Health ServicesN/AFMSFresenius Medical Care AG & Co. KGaA8.37%GHGuardant Health92.60%NTRANatera99.90%Insider OwnershipCompanyInsider OwnershipBTSGBrightSpring Health Services2.80%FMSFresenius Medical Care AG & Co. KGaAN/AGHGuardant Health5.60%NTRANatera5.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTSGBrightSpring Health Services23,500193.92 million188.49 millionOptionableFMSFresenius Medical Care AG & Co. KGaA1,488558.58 millionN/AOptionableGHGuardant Health2,506132.60 million125.17 millionNot OptionableNTRANatera6,140143.22 million135.15 millionOptionableFMS, NTRA, GH, and BTSG HeadlinesRecent News About These CompaniesPinnbrook Capital Management LP Increases Stock Position in Natera, Inc. $NTRAMay 22 at 6:34 AM | marketbeat.comNatera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in OncologyMay 21 at 5:05 PM | businesswire.comNatera's EXPAND Trial Enrollment Crosses 2,000 Patient MilestoneMay 21 at 1:31 PM | zacks.comNatera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the WorldMay 21 at 9:38 AM | finance.yahoo.comNatera, Inc. $NTRA Shares Sold by Eagle Health Investments LPMay 21 at 7:19 AM | marketbeat.comEXEL Collaborates With MRK for Late-Stage Colorectal Cancer StudyMay 20 at 3:35 PM | zacks.comEXPAND Trial of Natera’s Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients EnrolledMay 20 at 8:41 AM | finance.yahoo.comEXPAND Trial of Natera's Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients EnrolledMay 20 at 7:00 AM | businesswire.comThrivent Financial for Lutherans Lowers Holdings in Natera, Inc. $NTRAMay 20 at 6:48 AM | marketbeat.comHandelsbanken Fonder AB Increases Holdings in Natera, Inc. $NTRAMay 20 at 3:53 AM | marketbeat.comIs It Time To Reassess Natera (NTRA) After The Recent Share Price PullbackMay 19 at 10:10 PM | uk.finance.yahoo.comDNB Asset Management AS Has $5.68 Million Holdings in Natera, Inc. $NTRAMay 19 at 3:38 AM | marketbeat.comNatera jumps after Signatera CDx wins FDA companion diagnostic approval in bladder cancerMay 18, 2026 | quiverquant.comQNTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder CancerMay 18, 2026 | zacks.comSignateraâ„¢ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)May 15, 2026 | businesswire.comNatera, Inc. (NASDAQ:NTRA) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 13, 2026 | americanbankingnews.comNatera, Inc. (NASDAQ:NTRA) Receives Average Recommendation of "Moderate Buy" from BrokeragesMay 13, 2026 | marketbeat.comNTRA Q1 Deep Dive: Robust Volume Growth and Product Expansion Shape OutlookMay 12, 2026 | uk.finance.yahoo.comNatera (NASDAQ:NTRA) Given New $250.00 Price Target at BTIG ResearchMay 12, 2026 | americanbankingnews.comAssessing Natera (NTRA) Valuation After Recent Share Price Pullback And Long Term ReturnsMay 11, 2026 | finance.yahoo.comNatera (NTRA) Is Up 6.6% After Record Q1 Revenue But Wider Losses - Has The Bull Case Changed?May 11, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesApple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026These 3 Defense Giants Beat Q1 Estimates—So Why Did Their Stocks Still Fall?By Jessica Mitacek | April 22, 2026IonQ Just Posted a Breakout Quarter—But 1 Problem RemainsBy Nathan Reiff | May 7, 20265 Stocks to Buy in May Before the Next AI Surge HitsBy Thomas Hughes | May 1, 2026Roblox Stock Slides to New Low as Safety Changes Weigh on OutlookBy Jennifer Ryan Woods | May 3, 2026FMS, NTRA, GH, and BTSG Company DescriptionsBrightSpring Health Services NASDAQ:BTSG$58.49 +0.50 (+0.86%) As of 11:48 AM Eastern This is a fair market value price provided by Massive. Learn more.BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.Fresenius Medical Care AG & Co. KGaA NYSE:FMS$21.63 -0.87 (-3.88%) As of 11:48 AM Eastern This is a fair market value price provided by Massive. Learn more.Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.Guardant Health NASDAQ:GH$118.57 +0.56 (+0.47%) As of 11:48 AM Eastern This is a fair market value price provided by Massive. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Natera NASDAQ:NTRA$206.21 +2.52 (+1.24%) As of 11:48 AM Eastern This is a fair market value price provided by Massive. Learn more.Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Lowe's Finds Support at $215 After Q1 Earnings Sell-Off Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
